NCT03378310View on ClinicalTrials.gov

A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

February 22, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986205 reference tablet

Single, 100 mg oral dose.

DRUG

BMS-986205 tablet with free base

Single, 100 mg oral dose.

Trial Locations (1)

78744

PPD Austin Clinic, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY